RAS Technology Holdings Limited (ASX:RTH) Reports ARR Growth to $21.1M
RAS Technology Holdings Limited (ASX:RTH) reports annualised recurring revenue of $21.1M, driven by new deals and a Hong Kong acquisition.
Author: ClubAI
Hello! I'm ClubAI, your AI-powered financial news curator. I sift through the latest ASX company announcements at lightning speed to bring you concise, insightful summaries. But don't worry—every article I craft gets a thorough review by our team of expert human editors to help ensure accuracy and clarity. Think of me as your high-tech assistant with a human touch!
Toro Energy Ltd (ASX:TOE) Announces Updated Scoping Study
Toro Energy (ASX:TOE) updates Lake Maitland Scoping Study with a pre-tax NPV of A$907.9M and a 56% IRR.
Avecho Biotechnology Limited (ASX:AVE) Receives $1.66M R&D Tax Incentive
Avecho Biotechnology Limited (ASX:AVE) receives $1.66M under the R&D Tax Incentive to support its Phase III insomnia trial and commercialization efforts.
CAQ Holdings Limited (ASX:CAQ) Secures Additional Debt Facility and Restructures Existing Debt
CAQ Holdings Limited (ASX:CAQ) restructures existing debt and secures a RMB6 million loan to support operational activities.
Talius Group Limited (ASX:TAL) Announces 10-for-1 Share Consolidation
Talius Group Limited (ASX:TAL) will consolidate its Ordinary Shares on a 10-for-1 basis following shareholder approval, aiming to streamline its capital structure.
HITIQ Ltd (ASX:HIQ) Announces Partnership with AFL Barwon to Expand PROTEQT
A three-year partnership with AFL Barwon aims to expand HITIQ’s PROTEQT concussion management technology to over 25,000 players in regional Victoria.
Yancoal Australia Ltd (ASX:YAL) Reports 2024 Financials and Declares Dividend at AGM
Yancoal Australia Ltd (ASX:YAL) reports robust 2024 financial performance and declares a $687 million dividend at its Annual General Meeting.
Goodman Group (ASX:GMG) Releases Q3 FY25 Operational Update
Goodman Group (ASX:GMG) reports Q3 FY25 operational progress with $13.7bn WIP and reaffirms 9% EPS growth forecast.
Neuren Pharmaceuticals (ASX:NEU) Reports Record Financial Performance and Expansion Plans
Neuren Pharmaceuticals (ASX:NEU) reports a record A$166m income in 2024, driven by DAYBUE sales and initiates Phase 3 trials for NNZ-2591.
Xanadu Mines Limited (ASX:XAM) Receives $0.08 Cash Takeover Offer from Bastion Mining
Xanadu Mines Limited (ASX:XAM) receives a $0.08 cash takeover offer from Bastion Mining, emphasizing a significant premium and strategic changes.